Review
Copyright ©The Author(s) 2020.
World J Clin Oncol. May 24, 2020; 11(5): 250-259
Published online May 24, 2020. doi: 10.5306/wjco.v11.i5.250
Figure 1
Figure 1 Safety level for indication of immunotherapeutic drugs in the treatment of lung cancer. SCLC: Small-cell lung cancer; NSCLC: Non-small-cell lung cancer.